Status
Conditions
Treatments
About
This study is a randomized, double-blind, placebo-controlled trial aimed primarily at investigating the effects of Weizmannia coagulans BC99 on alleviating anxiety and depression and the gut microbiota.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
5)Ability and willingness to voluntarily participate in the study and to provide written informed consent prior to enrollment.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
79 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal